IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
85.17
-1.18 (-1.37%)
At close: Sep 24, 2026, 4:00 PM EDT
85.20
+0.03 (0.04%)
After-hours: Sep 24, 2026, 7:30 PM EDT
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, IRADIMED CORPORATION stock has a consensus rating of "Strong Buy" and an average price target of $118. The average 1-year stock price forecast is 38.55% higher than the current stock price, while the lowest is $116 (+36.21%) and the highest is $120 (+40.90%).
Price Target: $118 (+38.55%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 3, 2026.
Analyst Ratings
The average analyst rating for IRADIMED CORPORATION stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Reiterates $120 | Buy | Reiterates | $120 | +40.90% | Aug 3, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Initiates $116 | Buy | Initiates | $116 | +36.21% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
92.07M
from 83.81M
Increased by 9.85%
Revenue Next Year
104.10M
from 92.07M
Increased by 13.07%
EPS This Year
2.11
from 1.93
Increased by 9.50%
EPS Next Year
2.45
from 2.11
Increased by 16.09%
EPS and Forward PE are based on non-GAAP adjusted numbers.